Searchable abstracts of presentations at key conferences in endocrinology

ea0086cc7 | Featured Clinical Case Posters | SFEBES2022

Cholestyramine as monotherapy for thyrotoxicosis: experience at a tertiary care centre during COVID-19 pandemic

Iqbal Fizzah , Yin Win , Nijith Lakshmi , Lansdown Andrew , Taylor Peter , Witczak Justyna

Introduction: Thionamides are the mainstay of management of thyrotoxicosis but can be associated with adverse effects like agranulocystosis, hepatitis and vasculitis. While radioactive iodine and thyroidectomy can be utilized in such scenarios, they were not timely available during the COVID pandemic. We present our experience of using cholestyramine as monotherapy.Case Series: Our series consists of four females. Graves’ disease was the underlying ...

ea0086p159 | Adrenal and Cardiovascular | SFEBES2022

An audit of the clinical utility of urine steroid profiling for endocrine disorder diagnosis in a routine clinical laboratory in 2021

Taylor David , Churchus Richard , Collins Heather , Ajaj Nicola , Ekundayo Susan , Alramadhi Ulfat , Rayner Oliver , Ghataore Lea

Measurement of steroid metabolites in urine by gas chromatography-mass spectrometry remains the gold standard for biochemical diagnosis of steroidogenic disorders. In the UK, three laboratories offer steroid profiling for routine clinical testing, with the Supraregional Assay Service at King’s College Hospital being the largest and experiencing increased demand year-on-year for testing. In this study, we used our profiling database to audit 2021 workload. By direct compar...

ea0086p52 | Metabolism, Obesity and Diabetes | SFEBES2022

Nrf2 activator Sulforaphane attenuates maternal adiposity and hepatic steatosis

Psefteli Paraskevi-Maria , Balagamage Alokya , Morris Jessica , Taylor Paul , Mann Giovanni , Chapple Sarah

Intro/Aims: Maternal obesity is a major risk factor for the development of first onset of diabetes in pregnancy, also known as gestational diabetes mellitus (GDM). Recent studies also indicate that non-alcoholic fatty liver disease (NAFLD) is an independent predictor of GDM. Sulforaphane (SFN) is a well-known dietary activator of the redox-sensitive transcription factor Nrf2, with reported anti-adipogenic and NAFLD ameliorating effects in non-pregnant obese rodent models. In t...

ea0086p55 | Metabolism, Obesity and Diabetes | SFEBES2022

Effect of sulforaphane, an activator of the Nrf2 antioxidant defence pathway, on maternal adiposity in a model of diet-induced insulin resistant pregnancy

Balagamage Alokya , Psefteli Paraskevi-Maria , Morris Jessica , Taylor Paul , Mann Giovanni , Chapple Sarah

The incidence of maternal obese and/or gestational diabetic (GDM) pregnancy are increasing globally, with ~10-20% of mothers classified as obese and/or GDM within the U.K. Both obese and GDM pregnancy are associated with increased risk of cardiometabolic disease, with mothers and their children at greater risk of developing later-life Type 2 diabetes, obesity and/or cardiovascular disease. Higher adiposity in pregnancy leads to increased inflammation, which may be countered by...

ea0069p19 | Poster Presentations | SFENCC2020

Hypoglycaemia associated with high grade transformation of a previously non-functioning pancreatic neuroendocrine tumour (pNET)

Mehta Ria , Taylor Rory , Patel Milan , Alves Anneke , Goldin Robert , Starling Naureen , Morganstein Daniel

Section 1: Case history: 75 year old female diagnosed with Grade 1 pNET (Ki-67 index 70%) in 2018. Treated with subtotal pancreatectomy but 8 months post-surgery a follow up scan showed new liver metastases, at which point she was commenced on lanreotide. 3 months later she presented with an 8 week history of episodic weakness, sweating and confusion consistent with hypoglycaemia. These episodes initially improved with eating but had become more severe and unresponsive to carb...

ea0065p138 | Endocrine Neoplasia and Endocrine Consequences of Living with and Beyond Cancer | SFEBES2019

Targeting oestrogen synthesis and action as a novel therapy for colorectal cancer

Sidhu Daljit , Haime Hope , Pidd Aidan , Taylor Angela , Cox Liam , Foster Paul

Colorectal cancers (CRC) represent 9.4% of all cancers, with about 42 000 new UK cases per year. Current treatment involves surgical resection followed by radio- and chemo-therapy. 5-Fluorouracil is the standard post-operative chemotherapy although tolerance is poor due to dose-limiting toxicities and drug-resistance. New treatment strategies are therefore sorely needed. One emerging chemotherapeutic option is to target oestrogen metabolism. Our novel work rev...

ea0065p217 | Metabolism and Obesity | SFEBES2019

A novel method for analysis of 11 oestrogens using high-throughput liquid chromatography tandem mass spectrometry

Gilligan Lorna , Goymer Lauren , Toor Harjeavon , Cox Grace , Shaheen Fozia , Arlt Wiebke , Taylor Angela

Oestrogen quantification in serum is challenging as concentrations are low, especially in men and post-menopausal women. Additionally, oestrogens do not ionise readily and structure similarities can lead to cross-reactivity and reduced specificity, especially with immunoassay. Full characterisation of oestrogen metabolism and its role in disease progression has therefore not been fully investigated. We aimed to develop and validate a liquid chromatography mass spectrometry met...

ea0065p229 | Metabolism and Obesity | SFEBES2019

Steroid deconjugation by helix pomatia – can we overcome snail speed?

Shaheen Fozia , Gilligan Lorna , Berner Camila , Callejas Jose Luis , Shackleton Cedric , Arlt Wiebke , Taylor Angela

Gas chromatography–mass spectrometry (GC–MS) has been used for urinary steroid analysis for over 50 years. The process of hydrolysis to release steroids from their conjugates is routinely performed using commercially available snail Helix-Pomatia sulfatase (HP). However, as this is a naturally occurring enzyme its production process results in batch variation and so each batch requires experimental validation to adjust for the difference in efficiency of the enzymati...

ea0065p230 | Metabolism and Obesity | SFEBES2019

Acute changes in steroid biosynthesis in patients following severe trauma: the golden hour study

Taylor Angela , Bentley Conor , Foster Mark , Lord Janet , Hazeldine Jon , Arlt Wiebke

Advancements in medical care have significantly improved survival rates following major traumatic injury. An understanding of the hormonal, inflammatory and metabolic changes that occur following trauma is still evolving but it is clear that they impact significantly upon patient prognosis. To date, studies that have examined trauma-induced changes in steroid metabolism have analysed samples taken from patients post-hospital admission, culminating in marked variability in the ...

ea0065p305 | Neuroendocrinology | SFEBES2019

Can a hypernatraemia alert system protect inpatients with diabetes insipidus?

Hakim Yasmin , Hoque Nahid , Gurung Ankit , Taylor David , Rao Nandini , Whitelaw Ben

Background: Over the past decade there has been increased recognition of the dangers associated with inpatient management of diabetes insipidus (DI) and omission of desmopressin leading to hypernatremia. In May 2009 a patient died from diabetes insipidus mismanagement in a London hospital. An NHS England patient safety alert was issued in 2016 highlighting this risk.Method: Inpatients with a serum sodium of 155 mmol/l or greater were prospectively identi...